CBDCA + Pemetrexed + Bevacizumab and Its Maintenance Chemotherapy in a Case of Solitary Breast Metastasis from a Lung Adenocarcinoma Resistant to Gefitinib

Based on the AVAPERL trial (36th ESMO 2011), CBDCA + pemetrexed + bevacizumab and its maintenance chemotherapy with pemetrexed + bevacizumab is a new promising regimen for the treatment of advanced non-small-cell lung adenocarcinoma. Herein, we report the rare case of a patient with solitary breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Kazuhide, Takeyama, Yoshihiro, Yoshihara, Motoi, Kato, Toshio, Hashimoto, Hiroyuki, Fukui, Yasutaka, Gonda, Hideo, Suzuki, Ryujiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
October, 2012
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492973/
https://www.ncbi.nlm.nih.gov/pubmed/23139670
http://dx.doi.org/10.1159/000343678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492973/
https://www.ncbi.nlm.nih.gov/pubmed/23139670
http://dx.doi.org/10.1159/000343678

Ejemplares similares